Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 15;20(20):6063-72.
doi: 10.1016/j.bmc.2012.08.023. Epub 2012 Aug 28.

Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties

Affiliations

Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties

Rakesh et al. Bioorg Med Chem. .

Abstract

A series of tetracyclic nitrofuran isoxazoline anti-tuberculosis agents was designed and synthesized to improve the pharmacokinetic properties of an initial lead compound, which had potent anti-tuberculosis activity but suffered from poor solubility, high protein binding and rapid metabolism. In this study, structural modifications were carried on the outer phenyl and piperidine rings to introduce solubilizing and metabolically blocking functional groups. The compounds generated were evaluated for their in vitro antitubercular activity, bacterial spectrum of activity, solubility, permeability, microsomal stability and protein binding. Pharmacokinetic profiles for the most promising candidates were then determined. Compounds with phenyl morpholine and pyridyl morpholine outer rings were found to be the most potent anti-tuberculosis agents in the series. These compounds retained a narrow antibacterial spectrum of activity, with weak anti-Gram positive and no Gram negative activity, as well as good activity against non-replicating Mycobacterium tuberculosis in a low oxygen model. Overall, the addition of solubilizing and metabolically blocked outer rings did improve solubility and decrease protein binding as designed. However, the metabolic stability for compounds in this series was generally lower than desired. The best three compounds selected for in vivo pharmacokinetic testing all showed high oral bioavailability, with one notable compound showing a significantly longer half-life and good tolerability supporting its further advancement.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A. 1 Initial lead anti-tubercular nitrofuran. In this study targeted changes were made to the outer C and D ring systems to improve ADME properties. B. Comparator oxazolidinone antibacterial agents Linezolid and Sutezolid with similar linear structures.
Scheme 1
Scheme 1
Reagents and conditions: a) tributyl (vinyl)tin, PdCl2(PPh3)2, DMF, MW, 160°C, 5 min; b) morpholine, Pd(OAc)2, 2-(Di-tert-butylphosphino) biphenyl, NaOtBu, toluene, 80°C, 12 h; c) Et3N, CHCl3, RT, 2h
Scheme 2
Scheme 2
Reagents and conditions: a) thiomorpholine, Pd(OAc)2, 2-(Di-tert-butylphosphino) biphenyl, NaOtBu, toluene, 80 °C, 12 h; b) 5, Et3N, CHCl3, RT, 2h; c) NalO4, CH3CN, MeOH, H2O, RT, 12 h
Scheme 3
Scheme 3
Reagents and conditions: a) N,N'-dimethyl ethylene diamine, CuI, K2CO3, toluene, reflux, 6 h; b) 5, Et3N, CHCl3, RT, 2h

Similar articles

Cited by

References

    1. Bailer AJ. Testing for the equality of area under the curves when using destructive measurement techniques. J Pharmacokinet Biopharm. 1988;16:303–309. - PubMed
    1. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167:1472–1477. - PubMed
    1. Singh R, Manjunatha U, Boshoff HI, Ha YH, Niyomrattanakit P, Ledwidge R, Dowd CS, Lee IY, Kim P, Zhang L, Kang S, Keller TH, Jiricek J, Barry CE., 3rd PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science. 2008;322:1392–1395. - PMC - PubMed
    1. Tangallapally RP, Sun D, Rakesh, Budha N, Lee REB, Lenaerts AJM, Meibohm B, Lee RE. Discovery of novel isoxazolines as anti-tuberculosis agents. Bioorg. Med. Chem. Lett. 2007;17:6638–6642. - PMC - PubMed
    1. Tangallapally RP, Yendapally R, Lee RE, Lenaerts AJM, Lee RE. Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents. J Med Chem. 2005;48:8261–8269. - PMC - PubMed

Publication types

LinkOut - more resources